Tsuyoshi Ohta

8PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 17, 2026
Prognosis and risk factors by histologic type of malignant ovarian germ cell tumors in Japan: a JSOG gynecologic tumor registry-based study.

|Feb 13, 2026
Clinical and prognostic insights into Trousseau's syndrome in gynecologic malignancies: a multicenter study.

Hemian Zhang, Masayuki Futagami, Rie Miura

|Nov 27, 2024
Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study).

Tadahiro Shoji, Eriko Takatori, Takayuki Nagasawa

|Jul 29, 2023
Mechanism of Cell Death by Combined Treatment with an xCT Inhibitor and Paclitaxel: An Alternative Therapeutic Strategy for Patients with Ovarian Clear Cell Carcinoma.

Urara Idei, Tsuyoshi Ohta, Hizuru Yamatani

|Jan 08, 2023
Honeycomb-like Structured Film, a Novel Therapeutic Device, Suppresses Tumor Growth in an In Vivo Ovarian Cancer Model.

Tsuyoshi Ohta, Masaru Tanaka, Seitaro Taki

|Oct 17, 2022
Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study.

Manabu Seino, Satoru Nagase, Tsuyoshi Ohta

Pageof 2

Frequent Collaborators

6 joint publications

Satoru Nagase

3 joint publications

Wataru Yamagami

3 joint publications

Yoshihito Yokoyama

3 joint publications

Hideki Tokunaga